ENVERIC

Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogen therapeutics for the treatment of neuropsychiatric disorders... Enveric is advancing the EVM301 Series, expected to offer a first-in-class, new approach to the treatment of difficult-to-address anxiety, depression and other disorders, mediated by the promotion of neuroplasticity without also inducing hallucinations in the patient.

Also known as: Enveric Biosciences, Enveric Biosciences, Inc., Enveric Therapeutics, Pty. Ltd.

Primary location: Naples United States